In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c09243 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2024. Written by Pengfei Pei and 12 co-authors. Institution: State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100…. Major MEDLINE topics: Heparan Sulfate, Glycocalyx, Peptides, Antineoplastic Agents. Cited 2 times so far (Crossref); 58 references. Funded by: National Key Research and Development Program of China, China Postdoctoral Science Foundation, China-Japan Friendship Hospital.
Abstract (original language)
Heparan sulfate (HS) is a major component of cell surface glycocalyx with extensive negative charges and plays a protective role by preventing toxins, including small molecule drugs and anticancer cationic lytic peptides (ACLPs), from cells. However, this effect may compromise the treatment efficiency of anticancer drugs. To overcome the impedance of cancer cell glycocalyx, an HS-targeting ACLP PTP-7z was designed by fusion of an ACLP and a Zn2+-binding HS-targeting peptide. Upon Zn2+ ion binding, PTP-7z could self-assemble into uniform nanoparticles and show improved serum stability and reduced hemolysis, which enable it to self-deliver to tumor sites. The peptide PTP-7z showed a pH- and Zn2+ ion-dependent HS-binding ability, which triggers the HS-induced in situ self-assembling on the cancer cell surface in the acidic tumor microenvironment (TME). The self-assembled PTP-7z can overcome the impedance of cell glycocalyx by either disrupting cell membranes or translocating into cells through endocytosis and inducing cell apoptosis. Moreover, PTP-7z can also inhibit cancer cell migration. These results proved that HS-responsive in situ self-assembling is a practical strategy to overcome the cancer cell glycocalyx barrier for ACLPs and could be extended to the design of other peptide drugs to promote their in vivo application.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China.
- Institute of Medical Science, China-Japan Friendship Hospital, Beijing 100029, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
- Department of Chemistry, Chemical Biology, and Biomedical Engineering, Stevens Institute of Technology, Hoboken, New Jersey 07030, United States.
Funding
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
- China-Japan Friendship Hospital
- Beijing University of Chemical Technology
- Natural Science Foundation of Beijing Municipality
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing
Cite
APA
Pei, P., Chen, L., Guan, X., Wei, P., Kang, X., Gong, L., Liu, L., Guo, W., Gu, R., Wang, L., Zhao, C., Liang, J. F., & Luo, S. Z. (2024). In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c09243
Vancouver
Pei P, Chen L, Guan X, Wei P, Kang X, Gong L, et al. In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c09243
BibTeX
@article{Pei2024,
author = {Pei, Pengfei and Chen, Long and Guan, Xinyao and Wei, Peng and Kang, Xiaoxu and Gong, Lili and Liu, Lihong and Guo, Wenxu and Gu, Renji and Wang, Lixin and Zhao, Chuanke and Liang, Jun F and Luo, Shi-Zhong},
title = {In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c09243}
}
EUVIMED